INS and Insulin resistance: Amer et al. investigated the potential role of insulin resistance through the expression of insulin receptors as a metabolic immune checkpoint leading to NK impairment and eventual MASH progression and suggested a new cellular insulin checkpoint through which NK cells contribute to fibrosis in patients with MAFLD [22].